ArticlePloS one2025
Analysis and forecast of hand, foot, and mouth disease epidemic trends in Guangzhou, China, 2013-2023.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hand, foot, and mouth disease (HFMD) primarily affects children under the age of five and has emerged as a significant public health concern in China. This study examines HFMD incidence trends across various gender and age demographics in Guangzhou from 2013 to 2023, providing a comprehensive overview to inform future prevention and management strategies. Utilizing epidemiological data from the National Notifiable Infectious Disease Reporting Information System, we employed Joinpoint regression modeling to assess variations in incidence rates among different demographic cohorts and developed a Seasonal Autoregressive Integrated Moving Average (SARIMA) model to analyze case trends and project future occurrences. The findings revealed biennial peaks and notable seasonality, indicating cases across all age groups, though predominantly among children under five. Joinpoint regression analysis demonstrated a significant decrease in incidence rates for children younger than one year (Average Annual Percent Change [AAPC]=-13.50%, P < 0.001) and those aged one year (AAPC = -10.35%, P = 0.002), while incidence remained stable for children aged two to five years. Conversely, a significant upward trend was identified in children aged six years and older (AAPC = 13.09%, P = 0.019). Gender-specific trends closely resembled these overall patterns, with both males and females experiencing similar percentage changes in incidence rates. The SARIMA model indicates a projected decline in HFMD cases for 2024, followed by a phase of relative stability characterized by minor fluctuations. These results offer crucial insights into HFMD trends, illustrating the effectiveness of current preventive measures in reducing incidence among younger children while underscoring the necessity for targeted interventions to address the rising trends in older age groups. By leveraging these findings, health authorities can refine control strategies and prioritize public health responses to effectively mitigate HFMD outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.